SPG(SH:600529) Ge Long Hui A P P·2026-01-13 13:29Group 1 - The core point of the article is that Shandong Pharmaceutical Glass (600529.SH) announced a plan to issue A-shares to specific entities, which will lead to a change in the company's control [1] - The shares will be issued to China International Pharmaceutical Health Co., Ltd., a wholly-owned subsidiary of China National Pharmaceutical Group Corporation, and its domestic subsidiary Shandong Yaoxin Health Industry Co., Ltd. [1] - The total amount of funds raised from this issuance is expected to be 3,235.12 million yuan, and the net proceeds after deducting issuance costs will be used entirely to supplement working capital [1] Group 2 - Before the issuance, the direct controlling shareholder of the company was Shandong Luzhong Investment Co., Ltd., with the actual controller being the Finance Bureau of Yiyuan County, Shandong Province [1] - After the issuance, China International Pharmaceutical Health Co., Ltd. will become the controlling shareholder, and the actual controller will change to China National Pharmaceutical Group, with the ultimate controller being the State-owned Assets Supervision and Administration Commission of the State Council [1] - This issuance constitutes a related party transaction but will not affect the company's compliance with listing conditions regarding share distribution [1]